Literature DB >> 16522282

Low-carbohydrate or low-fat diets for the metabolic syndrome?

Michael L Dansinger1, Ernst J Schaefer.   

Abstract

This report discusses a variety of considerations and reviews recent clinical trial data relevant to the question of which dietary approach is optimal for treatment and prevention of the metabolic syndrome. Special emphasis is given to the question of whether the degree to which metabolic syndrome features are observed in an individual patient should correspond to the degree to which carbohydrate restriction should be recommended. Short-term metabolic studies lend support to this concept, but longer-term effectiveness trials suggest the degree of dietary adherence and associated weight losses, rather than diet type, are the key predictors of metabolic cardiac risk factor reduction.

Entities:  

Mesh:

Year:  2006        PMID: 16522282     DOI: 10.1007/s11892-006-0053-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  52 in total

Review 1.  American College of Endocrinology position statement on the insulin resistance syndrome.

Authors:  Daniel Einhorn; Gerald M Reaven; Rhoda H Cobin; Earl Ford; Om P Ganda; Yehuda Handelsman; Richard Hellman; Paul S Jellinger; David Kendall; Ronald M Krauss; Naomi D Neufeld; Steven M Petak; Helena W Rodbard; John A Seibel; Donald A Smith; Peter W F Wilson
Journal:  Endocr Pract       Date:  2003 May-Jun       Impact factor: 3.443

2.  Reduced-carbohydrate diets: no roll in weight management?

Authors:  Walter C Willett
Journal:  Ann Intern Med       Date:  2004-05-18       Impact factor: 25.391

3.  Is a low-carb, low-fat diet optimal?

Authors:  Eric C Westman; William S Yancy; Mary C Vernon
Journal:  Arch Intern Med       Date:  2005-05-09

4.  The effect of diets high in protein or carbohydrate on inflammatory markers in overweight subjects.

Authors:  A Due; S Toubro; S Stender; A R Skov; A Astrup
Journal:  Diabetes Obes Metab       Date:  2005-05       Impact factor: 6.577

5.  A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women.

Authors:  Bonnie J Brehm; Randy J Seeley; Stephen R Daniels; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

Review 6.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

7.  Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults.

Authors:  Cara B Ebbeling; Michael M Leidig; Kelly B Sinclair; Linda G Seger-Shippee; Henry A Feldman; David S Ludwig
Journal:  Am J Clin Nutr       Date:  2005-05       Impact factor: 7.045

8.  Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects.

Authors:  G D Brinkworth; M Noakes; J B Keogh; N D Luscombe; G A Wittert; P M Clifton
Journal:  Int J Obes Relat Metab Disord       Date:  2004-05

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men.

Authors:  Matthew J Sharman; Ana L Gómez; William J Kraemer; Jeff S Volek
Journal:  J Nutr       Date:  2004-04       Impact factor: 4.798

View more
  2 in total

1.  A diabetes drama for President Obama.

Authors:  Michael Dansinger
Journal:  Medscape J Med       Date:  2009-01-30

2.  Exercise based lifestyle intervention in obese adults: results of the intervention study m.o.B.I.L.I.s.

Authors:  Aloys Berg; Andreas Berg; Ingrid Frey; Daniel König; Hans-Georg Predel
Journal:  Dtsch Arztebl Int       Date:  2008-03-14       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.